Statement of Principles concerning malignant neoplasm of the larynx (Reasonable Hypothesis) (No. 41of 2022)

The instrument centres on several legal and medical-conceptual building blocks.

Reasonable hypothesis: The SoP is titled “Reasonable Hypothesis”. It frames the question as whether a reasonable hypothesis has been raised connecting malignant neoplasm of the larynx or death from the condition with relevant service. The instrument does not define the judicial test of “reasonable hypothesis” within its text; instead it supplies the factual factors which, if proven and related to relevant service, suffice to raise that hypothesis (see s 9 and s 10).

Clinical onset: The temporal anchor used throughout the factors is “clinical onset of malignant neoplasm of the larynx”. That phrase is used repeatedly as the reference point for minimum latency periods and cessation windows (see, for example, s 9(1)(b), (2)(b), (3), (4)(b), (6)(b), (7)(b), etc.). The instrument does not define “clinical onset” within its Schedule 1 Dictionary; hence the SoP requires claimants and decision makers to locate and rely on clinical records, specialist notes, or pathology reports to establish the date on which clinical onset occurred.

Quantitative exposure thresholds and time windows: The SoP is highly prescriptive about the quantity, duration and timing of exposures that will satisfy the reasonable‑hypothesis threshold. Examples include:

• Smoking: at least 1.5 pack‑years, commencing at least 5 years before clinical onset; if smoking ceased, onset must be within 20 years of cessation (s 9(1)). The instrument defines “one pack‑year” and gives a conversion to grams of tobacco (Schedule 1).
• Second‑hand smoke: at least 5,000 hours in an enclosed space, commencing at least 5 years before clinical onset; cessation window 20 years (s 9(2)).
• Asbestos: distinct cumulative hour thresholds for inhalation in enclosed spaces (1,000 hours) and open environments (3,000 hours), both with first inhalation at least 5 years before clinical onset (s 9(4)‑(5)).
• Wood/biomass smoke: inhalation in an enclosed space for at least 7,500 hours, commencing at least 5 years before clinical onset (s 9(6)).
• Alcohol: at least 100 kilograms of alcohol within any 10 year period, with consumption at least 5 years before clinical onset and a 40‑year cessation window (s 9(7)). The Schedule defines alcohol’s calculation using the Australian standard of 10 grams per standard drink (note to s 9(7)).

Causal scope: The instrument covers both the disease and death from the disease. For death‑related claims, the SoP treats death as included where the person’s malignant neoplasm of the larynx contributed to a terminal event or condition (s 7(5)). The instrument defines “terminal event” in the Schedule 1 Dictionary and lists proximate causes such as pneumonia, respiratory failure, cardiac arrest, circulatory failure and cessation of brain function.

Cross‑referencing to other SoPs and to external classification: The SoP expressly allows factors that refer to other injuries or diseases to import the factors in those other SoPs, in accordance with their terms (s 11). The instrument also references the ICD‑10‑AM code C32 (s 7(3)-(4)) but specifies the textual definition in s 7(2) should be used for applying the SoP.

Relevant service and relationship: “Relevant service” is defined in Schedule 1 and encompasses operational, peacekeeping, hazardous, British nuclear test defence, and MRCA warlike and non‑warlike service (Schedule 1,relevant service). The SoP requires that any factor proven to exist must be related to the person’s relevant service (s 10(1)). In other words, an exposed claimant must show that the exposure demonstrated by s 9 actually occurred in circumstances connected to their relevant service.

Technical definitions and activity‑based lists: The Schedule supplies technical definitions and activity lists that add operational meaning to factors: for example, “having been exposed to second‑hand smoke” is defined as being in an enclosed space inhaling smoke from burning tobacco or exhaled smoke (Schedule 1), and an extensive list of activities and chemicals defines what constitutes exposure to TCDD‑contaminated chemical agents (Schedule 1 definition for inhaling/ingesting/contact with chemical agent contaminated by TCDD). “Specified industry, manufacturing process or agent” is defined as seven discrete categories (aluminium production, coke production, iron and steel founding, metalworking fluids, printing, rubber production, soot during cleaning of chimneys or flues), thereby tying the polycyclic aromatic hydrocarbons factor to those industries (Schedule 1).

Together these concepts make the SoP a rulebook of discrete, evidence‑oriented thresholds that link quantified exposures and specified medical states to a judgmental device , the reasonable hypothesis connecting disease and relevant service.

The instrument affects veterans, members of Peacekeeping Forces, and members of the Forces whose claims fall under sections 120A of the VEA or 338 of the MRCA (s 5; Schedule 1 definitions of relevant service). It operates as a medico‑legal predicate in administrative decision making: claimants seeking a finding that malignant neoplasm of the larynx is connected to their service will be assessed against the factors in s 9 and the relationship requirement in s 10.

Primary affected parties

• Claimants: individuals who have malignant neoplasm of the larynx (as defined at s 7(2)) or who died from the disease and who assert that the disease was related to relevant service. Claimants bear the practical task of assembling evidence that meets the quantitative thresholds and temporal windows in s 9 and the linkage to relevant service under s 10.

• Decision makers and administrative clinicians: persons within the Department of Veterans’ Affairs or delegated medical officers who apply the SoP when deciding whether a reasonable hypothesis is raised for the purposes of s 120A VEA or s 338 MRCA. The SoP supplies a discrete evidentiary grid that these decision makers must apply.

Secondary affected parties

• Treating medical practitioners and forensic experts: clinicians will be asked to provide dated clinical records establishing “clinical onset”, pathology confirming the tumour falls within the textual definition in s 7(2), specialist reports showing infection status (HIV, HPV 16/18), transplantation history, GERD diagnosis and duration, and documentation of inability to obtain appropriate clinical management (s 9(11), (12), (13), (16), (20)). Experts may also be required to extrapolate cumulative exposure hours, pack‑year calculations, or occupational exposure histories.

• Employers, unit commanders and record‑keepers: bodies with custody of personnel records, occupational logs or ship logs may be asked to produce contemporaneous records demonstrating exposure environments (enclosed vs open), durations of exposure (hours), and locations of service (for example, being on land in Vietnam or at sea in Vietnamese waters as per Schedule 1).

• Legal advisers and advocates: lawyers and advocates preparing claims must marshal documentary and expert evidence that maps onto the SoP thresholds. This affects the structure and cost of claims because many factors require detailed, quantified histories.

Geographical and temporal reach

• The SoP is not geographically limited in its operation; however, one factor (s 9(9)) is explicitly tied to presence in Vietnam , land in Vietnam, at sea in Vietnamese waters, or consumption of potable water produced by evaporative distillation of estuarine Vietnamese waters , for at least a cumulative 30 days, at least five years before clinical onset. The Schedule defines “being on land in Vietnam; or at sea in Vietnamese waters” by reference to particular Items of Schedule 2 of the VEA (Schedule 1). Following amendment No. 27 of 2024, that definition refers to Items 3A, 3B, 4 and 8 of Schedule 2 of the VEA (endnote 3 and endnote 4).

Practical burdens and distributional effects

• Claim assemblage burden is concentrated on claimants: most factors require quantified evidence (cumulative hours, pack‑years, kilograms of alcohol) and temporally specific evidence (commencement at least five years before clinical onset, cessation windows). The SoP’s reliance on precise quantification shifts evidentiary burden toward documentary and expert material. Where exposures occurred in informal or chaotic environments (for example, field conditions, tents, shipboard life), evidence may be limited, increasing reliance on unit records, contemporaneous statements, or expert reconstruction.

• Medical‑administrative coordination: the SoP directs significant interaction across medical records, pathology reporting, and service records. The need to demonstrate infection with HPV 16/18, HIV status, organ transplantation, GERD duration, or inability to obtain appropriate clinical management places a burden on both claimants and treating clinicians to provide thorough, dated records.

Stakeholder incentives

• Claimants have an incentive to document quantity and timing of exposures since satisfying any one of the s 9 factors (and relating it to relevant service) raises the reasonable hypothesis.

• The department and its medical assessors are incentivised to apply the SoP’s detailed thresholds as an administrable standard, but must interpret terms not defined in the instrument, such as “clinical onset” or how to aggregate “cumulative hours” when records are incomplete.

In short, the SoP affects claimants, decision makers, medical experts, record custodians and legal advisers by replacing a general medical causation inquiry with a set of discrete, evidence‑dependent thresholds tied to service‑related exposures and defined medical states (s 9; s 10; Schedule 1).

This SoP creates duties of evidence and definitional gates rather than duties in the sense of active conduct requirements. It confers rights to a particular mode of assessment for claimants under the VEA/MRCA and obliges decision makers to apply the SoP when a claim falls within the specified sections.

Duties and expectations placed on decision makers

• Apply the SoP in claim assessment: The instrument applies to a claim to which s 120A VEA or s 338 MRCA applies (s 5). Decision makers charged with adjudication of those claims must apply the SoP’s factors to determine whether a reasonable hypothesis has been raised connecting the disease to relevant service.

• Use the instrument’s textual definitions: Where a disease is associated with an ICD‑10‑AM code (C32), the SoP instructs decision makers to apply the textual definition in subsection 7(2) rather than relying solely on the classification (s 7(3)-(4)). That is an obligation to prefer the SoP’s substantive description in assessing eligibility.

• Relate factors to relevant service: For a factor in s 9 to contribute to raising the reasonable hypothesis, the factor must be related to the person’s relevant service (s 10(1)). Decision makers therefore must evaluate the nexus between the exposure or condition and the service record.

Duties or evidential thresholds for claimants

• Present evidence demonstrating at least one factor: Claimants must adduce evidence showing that at least one factor in s 9 exists and that it is related to relevant service (s 9; s 10). The factors are often expressed in quantitative terms (hours, pack‑years, kilograms of alcohol), so claimants must provide records or credible reconstructions to meet those thresholds.

• Establish timing relative to clinical onset: Many factors require exposures to have commenced at least five years before clinical onset or contain cessation windows (for example, s 9(1), (2), (3), (4), (5), (6), (7)). Claimants must secure medical evidence establishing the date of clinical onset.

Rights conferred by the SoP

• Right to the reasonable-hypothesis route: For claims within the SoP’s application (s 5), a claimant who satisfies the SoP’s factor(s) and the relationship requirement has the right to have the reasonable hypothesis recognised for the purposes of the VEA/MRCA claim process. The instrument supplies the legalised checklist that transforms certain factual showings into a presumption‑generating event under the broader statute.

• Importation of other SoPs: If a factor in s 9 refers to an injury or disease subject to another SoP, the claimant has the right to have that other SoP’s factors applied according to its terms (s 11). This avoids duplication of proof where an exposure or disease overlaps with another established SoP.

Limitations and conditional rights

• Factor 9(20) limitation: The factor concerning inability to obtain appropriate clinical management (s 9(20)) is limited by s 10(2). It can contribute only to material contribution to, or aggravation of, malignant neoplasm of the larynx where the disease was suffered or contracted before or during, but did not arise out of, the person’s relevant service. That is a duty‑limiting condition; claimants cannot use lack of clinical management after service to establish that the disease arose out of service where it did not.

• No substantive entitlements or penalties in the instrument: The SoP is evidentiary and definitional; it does not on its face grant monetary or other benefits nor set penalties for non‑compliance. Those substantive rights and enforcement mechanisms are contained in the parent Acts (VEA, MRCA) to which the SoP attaches.

Evidence duties implicit in the Schedule

• Use provided definitions and conversions: The Schedule sets conversion factors and definitions, such as “one pack‑year” and the equivalence of 7,300 grams of smoking tobacco to one pack‑year (Schedule 1). Claimants and decision makers must apply these definitions in quantifying exposures.

In summary, the instrument imposes duties of application upon decision makers and evidential burdens upon claimants: decision makers must apply the SoP’s textual definitions and factor thresholds; claimants must adduce the quantitative and temporal evidence required by s 9 and the relationship condition in s 10. The SoP does not itself create benefit entitlements or sanctions; those rights and enforcement pathways remain in the VEA/MRCA framework to which the SoP attaches.

The Statement of Principles itself contains no penalty provisions and does not create criminal or civil penalties. It is an instrument of medical causation and evidentiary specification made under subsection 196B(2) of the VEA (s 3). Its role is to guide administrative determination of claims under the VEA or MRCA when sections 120A (VEA) or 338 (MRCA) are engaged (s 5). Enforcement and any consequences for claim outcomes therefore flow from the application of the VEA or MRCA rather than from this instrument.

What the instrument enforces indirectly

• Adjudicative standard enforcement: The practical effect of the SoP is to enforce a single medico‑legal standard , the reasonable hypothesis , by prescribing which factual factors will, if established and linked to relevant service, satisfy that standard. Administrative decision makers must apply these factors when considering entitlement under the relevant statutory provisions. Failure by decision makers to apply the SoP in an applicable claim would be an error of administrative process; remedies for such error are available under the VEA/MRCA or administrative review pathways set out in those Acts and their review regimes, but those remedies and penalties are not stated in this instrument.

• Documentary and evidentiary consequence: If a claimant cannot demonstrate any of the factors in s 9, or cannot show the factor is related to relevant service (s 10), the reasonable hypothesis will not be raised under this SoP and the claim is likely to be unsuccessful. That is a consequential enforcement of the standard through decisions about entitlement.

No inspectorate or compliance‑penalty apparatus in the SoP

• The instrument does not establish an inspection regime, civil penalty framework, or criminal sanctions. There is no power to compel production of records contained in the SoP itself; such powers, if any, would arise from the VEA/MRCA or other statutes.

Interaction with review and appeal processes external to the instrument

• The SoP is part of the administrative decision framework; appellants dissatisfied with an administrative decision that rests upon or misapplies a SoP would need to rely on the statutory appeal and review mechanisms available under the VEA, MRCA, or general administrative law avenues. The SoP itself neither prescribes nor restricts those remedies.

Risks of administrative error and remedies

• Because the SoP places technical quantification obligations on evidence (pack‑years, cumulative hours, etc.), errors in evidence assessment or misapplication of definitions (for example, misreading the Schedule’s definition of “one pack‑year”) can occur. Remedies for such errors are governed by the parent Acts and administrative review pathways; the compiled instrument and its endnotes list amendment history and compilation details but do not set out appeal channels.

In short, enforcement is indirect: the SoP creates an evidentiary standard that administrative decision makers must apply in relevant claims under the VEA/MRCA. The instrument itself contains no penalty provisions, inspection powers, or enforcement sanctions; legal consequences flow through the parent Acts once the SoP is applied.

This SoP is situated within the statutory architecture of the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The instrument explicitly cross‑references and integrates with other legal instruments and classificatory systems.

Primary statutory relationship

• Made under VEA subsection 196B(2): The instrument is made under s 196B(2) of the VEA (s 3). It therefore operates as a legislative instrument under the authority of the VEA and in service of the VEA’s claim processing architecture. The SoP’s applicability is confined to claims to which s 120A of the VEA or s 338 of the MRCA apply (s 5).

• MRCA cross‑application: Where a claimant brings a claim under the MRCA (s 5), the SoP applies to claims to which s 338 MRCA applies. The Schedule defines MRCA for purposes of the instrument (Schedule 1).

Cross‑reference to other Statements of Principles

• Importation principle under s 11: Section 11 provides that if a factor in s 9 refers to an injury or disease covered by another SoP, then the factors in that other SoP apply according to that instrument’s terms. This creates a legal mechanism for cross‑SoP reliance, avoiding duplication where a particular exposure or disease is covered by separate SoPs. Practitioners must therefore cross‑check other SoPs when s 9 factors point to another disease or exposure.

Interaction with classification and external standards

• ICD‑10‑AM reference: The instrument notes the condition attracts ICD‑10‑AM code C32 but instructs that the textual definition in s 7(2) is to be used in applying the SoP (s 7(3)-(4)). It also points to the specific edition and effective date of the ICD‑10‑AM referenced (Tenth Edition, effective 1 July 2017) and attributes copyright to the Independent Hospital Pricing Authority (s 7(4)). This shows the instrument’s interaction with an external diagnostic classification while prioritising its own textual definition.

Interaction with VEA Schedule 2 for Vietnam service

• Definition of “being on land in Vietnam; or at sea in Vietnamese waters”: The Schedule defines that phrase by reference to Items 3A, 3B, 4 and 8 of Schedule 2 of the VEA (Schedule 1). The 2024 amendment (No. 27 of 2024) replaced that Schedule 1 definition so that the instrument’s Vietnam‑related factor (s 9(9)) must be interpreted by reference to the particular Items of Schedule 2 of the VEA, not by an independent geographic description. Practitioners therefore must consult Schedule 2 of the VEA to determine whether service falls within the instrument’s Vietnam trigger.

Interplay with other statutory evidence regimes

• The SoP is an evidentiary vehicle for the reasonable hypothesis in the VEA/MRCA claim process. While the instrument does not itself supply evidentiary rules about admissibility or burdens of proof, it must be applied in the context of the VEA/MRCA statutory evidentiary rules and any applicable administrative law constraints. The instrument’s schedule and notes require users to map exposures and conditions into other statutory definitions and external classifications.

Administrative law and appeals

• The instrument does not constrain or describe the appeal or review rights under the VEA/MRCA or other administrative law avenues. Errors in applying the SoP by decision makers would be susceptible to the usual administrative law remedies and appeal processes provided elsewhere in the statutory scheme.

Legislative instrument rules

• Compilation and amendment history: The compilation includes endnotes detailing registration and commencement dates and amendment history (endnotes 3 and 4). The instrument is a legislative instrument; certain sections were affected by the Legislation Act 2003 (endnote 4 notes sections republished/affected by LA provisions). Practitioners relying on the SoP must therefore pay attention to the compilation date (26 March 2024) and any uncommenced amendments available on the Register, as the endnotes caution.

In short, the SoP interacts with (1) the VEA and MRCA by definition and application, (2) other SoPs via s 11, (3) external classification systems (ICD‑10‑AM) and VEA Schedule 2 for Vietnam service, and (4) the broader administrative and legislative framework governing appeals, evidence and instrument amendment. Users must therefore read the SoP in conjunction with those instruments and materials.

The compiled instrument records its initial making and subsequent amendment(s). The compilation date is 26 March 2024 and the endnotes supply the amendment history (Endnotes 3 and 4).

Primary instrument and commencement

• Original registration: The Statement of Principles concerning malignant neoplasm of the larynx (Reasonable Hypothesis) was registered as No. 41 of 2022 on 2 May 2022 and commenced on 30 May 2022 (endnote 3). The compiled text reflects the instrument as in force on 26 March 2024.

Subsequent amendment

• Amendment No. 27 of 2024: An Amendment Statement of Principles concerning factors relating to being in Vietnam (Reasonable Hypothesis) (No. 27 of 2024) was registered 28 February 2024 and its day of commencement is recorded as 26 March 2024 (endnote 3). The compilation expressly notes that the day of commencement of this Amendment Statement of Principles is 26 March 2024.

Scope of the amendment

• Endnote 4 indicates specific provisions affected: the amendment history table shows that Section 2 and Section 4 were affected (described as “Section 2… rep LA s 48D” and “Section 4… rep LA s 48C”), and that Schedule 1 - Dictionary’s definition of “being (a) on land in Vietnam; or (b) at sea in Vietnamese waters” was replaced by instrument No. 27 of 2024 (Endnote 4). The compiled Schedule 1 now defines “being on land in Vietnam; or at sea in Vietnamese waters” by reference to Items 3A, 3B, 4 and 8 of Schedule 2 of the VEA.

Practical consequences of the amendment

• The key practical effect disclosed in the compilation concerns the Vietnam‑related factor (s 9(9)). Following the amendment, practitioners and claimants must map claimed Vietnam presence to the specified Items of Schedule 2 of the VEA. The amendment therefore imports the granularity and temporal/geographic limits contained in those Schedule 2 Items into this SoP’s Vietnam factor.

Compilation and editorial notes

• The compilation contains general material familiar to users of legislative instruments, such as notes on uncommenced amendments, modifications, self‑repealing provisions and how misdescribed amendments are handled (endnotes and accompanying apparatus). The endnotes caution that the compilation shows the law as amended and in force on the compilation date and that uncommenced amendments are not shown in the compiled text.

• The endnotes’ abbreviation key and legislative history tables further assist users locating the registration and commencement information and tracing the instrument’s amendments.

Continuing attention required

• Because the SoP is a legislative instrument in an active area of veterans’ medical determinations, practitioners should consult the Register for any amendments effected after the compilation date. The compilation notes uncommenced amendments and that modifications by other laws may not be displayed in the compiled text; therefore current practice requires consulting the Register and any related instruments.

In summary, the instrument was originally registered and commenced in 2022 and was amended in early 2024 to revise the dictionary definition related to being in Vietnam. The endnotes record precise registration and commencement dates and indicate which Schedule entries were replaced.

The compiled instrument itself contains no references to judicial decisions or litigation. The endnotes record legislative history, registration numbers and amendments (endnote 3 and 4), but they do not report any case law, judicial review outcomes, or decided disputes concerning the SoP. The instrument does not name any cases and the compilation does not include a litigation history section.

Practical implications of absent litigation reporting

• No reported challenge recorded in the compilation: The absence of reported litigation in the instrument compilation means users cannot rely on judicial interpretation of the SoP from the compilation alone. Any contested application of the SoP in claims , for example disputes over how to count cumulative exposure hours, the date of “clinical onset”, or the nexus to “relevant service” , will have to be resolved in the administrative review processes under the VEA/MRCA framework or in any judicial review proceedings brought in the relevant courts, but the compilation offers no summaries of such cases.

• Administrative appeal avenues remain: The instrument’s absence of litigation references does not affect a claimant’s ability to seek administrative review or judicial review under the statutory frameworks of the VEA or MRCA. However, resolving technical interpretive questions (for example, how to apply the Schedule’s pack‑year conversions, what establishes an “enclosed space” for second‑hand smoke) will likely depend on either administrative decisions, internal review findings, or, should a matter proceed, court determinations that are external to the compilation.

• Need for proactive evidentiary drafting: Because there is no reported litigation providing authoritative judicial gloss on contested definitions in this SoP, legal and medical advisers must be proactive in framing evidence, anticipating contested points (for example, the computation of “cumulative” hours, proof of “clinical onset”, or the mapping of Vietnam service to Schedule 2 Items), and preparing submissions that address the instrument’s textual requirements.

Recommendation for practitioners

• Check administrative decisions and tribunal decisions: Although the instrument itself does not record litigation, practitioners should search administrative decisions, Veteran’s Review Board outcomes, or court judgments post‑compilation to identify any developed jurisprudence on the instrument’s application. Such searches are external to the compiled instrument but necessary for a full practice picture.

In sum, the compilation contains no litigation history; practitioners must therefore rely on administrative practice and any post‑compilation judicial decisions when addressing contested questions of interpretation.

The SoP embeds a number of technical traps for the unwary. These are practical and legal points where evidence, timing, definitional scope or cross‑instrument referencing can materially affect a claim.

Reliance on “clinical onset” without definition

• The instrument uses “clinical onset” as the pivotal temporal anchor for many factors (s 9 generally). The SoP does not define “clinical onset” in Schedule 1. That omission transfers the task of fixing the onset date to medical records and expert interpretation. Disputes commonly arise over when clinical onset occurred (first symptom, first presentation, first diagnostic imaging, or biopsy confirmation). Practitioners must therefore obtain and carefully interpret dated clinical and pathology records rather than assuming a conventional onset date.

Quantitative thresholds require precise evidence

• Pack‑years, cumulative hours, and kilograms of alcohol: Several factors are expressed as precise quantitative thresholds (s 9(1) pack‑years; s 9(2) 5,000 hours second‑hand smoke; s 9(4) 1,000 hours enclosed asbestos; s 9(5) 3,000 hours open asbestos; s 9(6) 7,500 hours biomass/wood smoke; s 9(7) 100 kg alcohol in any 10 year period). Where contemporaneous records are absent, tribunals or decision makers must decide whether reconstructed evidence is sufficiently reliable. The Schedule provides a conversion for pack‑years (Schedule 1) but not for cumulative hours, leaving an evidentiary gap about how to aggregate intermittent exposures.

• Cumulative exposure aggregation: The instrument uses “cumulative period” (for example, asbestos exposures in s 9(4)-(5); PAHs in s 9(18)) without giving rules for aggregating non‑continuous exposures. Practitioners will need to map service diaries, work rosters, or witness statements into an hours tally. Expect challenge where exposures are episodic, as in short deployments with periodic exposure.

Enclosed vs open environment distinctions

• Asbestos and smoke exposures are differentiated by enclosed vs open environments with dramatically different thresholds (1,000 vs 3,000 hours for asbestos; 7,500 hours for wood smoke in enclosed spaces only). The SoP does not define “enclosed space” beyond the ordinary meaning; therefore cases involving ships, tents, open‑air but covered work sites, or poorly ventilated outdoor areas risk contested characterisation. Practitioners must secure detailed evidence describing the physical environment at the time of exposure.

Cross‑referencing to other SoPs

• Section 11 permits factors to import other SoPs when a factor in s 9 refers to an injury or disease covered by another SoP. However, there is a risk that claimants and advisers fail to identify and rely upon those other SoPs when necessary. This can occur where, for example, HPV infection is also the subject of another SoP that provides a different evidentiary grid. Practitioners must check for other SoPs that could supply additional or alternative routes to a reasonable hypothesis.

Vietnam factor requires cross-checking of Schedule 2 VEA Items

• The instrument’s definition of “being on land in Vietnam; or at sea in Vietnamese waters” refers to specific Items of Schedule 2 of the VEA (Schedule 1). The 2024 amendment replaced the prior definition. Practitioners cannot rely on a plain‑language geographic description; they must match dates and locations to the Items (3A, 3B, 4 and 8) of Schedule 2 of the VEA. Failure to do so can lead to misclassification of service and claim denial.

Factors that operate only as aggravation or contribution

• The inability to obtain appropriate clinical management factor (s 9(20)) is limited by s 10(2): it applies only to material contribution to, or aggravation of, malignant neoplasm of the larynx where the disease was suffered or contracted before or during, but did not arise out of, relevant service. This is a trap if advisers attempt to use factor 9(20) as a primary causal link when disease onset followed service. Practitioners must ensure they frame claims in the correct causation category (material contribution/aggravation versus causation arising out of service).

Exclusions in the disease definition

• The textual disease definition explicitly excludes carcinoid tumour, Hodgkin’s lymphoma, non‑Hodgkin lymphoma and soft tissue sarcoma (s 7(2)(b)). Claims relying on those histologies must be diverted to other SoPs or statutory channels; relying on this SoP for those conditions is a likely cause of rejection.

Implicit evidentiary burden for infections and biological markers

• Several factors require demonstration of infection status or biological markers (HIV, HPV16/18) or medical history (solid organ transplant) (s 9(11)-(13)). These require documented test results or reliable medical histories. For HPV 16/18 persistent infection, the SoP requires persistent infection of laryngeal epithelium; this is a specialised diagnostic requirement that will need histopathology and viral typing. Failure to secure precise medical documentation will impede the claim.

Time windows and cessation periods

• Many factors have post‑cessation windows (smoking 20 years, alcohol 40 years, maté 15 years) (s 9(1), (7), (14)). Claimants and advisers must be careful in calculating cessation dates. The Schedule’s pack‑year conversion guidance (Schedule 1) is precise; economic or social histories that do not anchor cessation dates precisely risk denying a otherwise arguable claim.

In sum, the main "gotchas" are definitional gaps (clinical onset), the SoP’s demand for exact quantification and temporal anchoring, environment characterisation (enclosed v open), cross‑SoP dependencies, and narrowly confined aggravation rules. Addressing these requires documentary rigor, attention to the Schedule’s technical conversions, and careful mapping of service records to statutory schedules and external SoPs.

Compliance in the context of this SoP means assembling and presenting evidence sufficient to establish (1) that the claimant has malignant neoplasm of the larynx as defined in s 7(2) or death contributed to by that disease (s 7(5)); (2) that at least one of the factors in s 9 exists according to its quantitative and temporal thresholds; and (3) that the proven factor is related to the claimant’s relevant service (s 10(1)). Below is a practical compliance checklist for advisers and claimants, grounded in the instrument’s text.

Step 1 , Confirm the diagnosis and histology

• Obtain and lodge pathology reports, ENT specialist reports and any surgical notes that confirm a primary malignancy of the mucosa of the larynx extending from the lower border of the hypopharynx to the upper border of the trachea (s 7(2)).

• Verify the tumour is not one of the exclusions in s 7(2)(b): carcinoid tumour, Hodgkin’s lymphoma, non‑Hodgkin lymphoma, or soft tissue sarcoma.

• For death claims, obtain death certificate, terminal event documentation and medical records showing the malignant neoplasm made a contribution to the terminal event listed in Schedule 1 (s 7(5); Schedule 1 terminal event list).

Step 2 , Establish clinical onset date

• Obtain the earliest dated clinical note indicating symptoms, presentation, imaging, biopsy or pathological confirmation. Because “clinical onset” is the temporal anchor for multiple factors (for example s 9(1)-(7)), ensure dates are precise. If there is ambiguity, commission a treating specialist or independent expert report providing a reasoned opinion on the clinical onset date referring to contemporaneous records.

Step 3 , Identify which s 9 factor(s) to rely upon

• Review s 9(1)-(20) and match the claimant’s exposure history and medical history to the relevant factor(s). Only one factor needs to be proven to raise the reasonable hypothesis, but multiple factors may be cumulative evidence.

Step 4 , Quantify exposures using the Schedule definitions

• Smoking: calculate pack‑years per Schedule 1: divide number of cigarettes per day by 20, multiply by years smoked. If using grams of smoking tobacco, use the Schedule’s equivalence (7,300 grams = one pack‑year) (Schedule 1; s 9(1)).

• Second‑hand smoke: quantify hours spent in enclosed spaces exposed to burning tobacco or exhaled smoke; ensure evidence shows at least 5,000 hours and that exposure commenced at least 5 years before clinical onset (s 9(2); Schedule 1).

• Asbestos exposures: document whether exposures occurred in enclosed or open environments and tally cumulative hours (1,000 enclosed; 3,000 open) with first inhalation at least 5 years before clinical onset (s 9(4)-(5)).

• Wood/biomass smoke: document enclosed‑space exposure hours (7,500 hours) (s 9(6)).

• Alcohol: document total alcohol consumption, using the Australian standard of 10 grams per standard drink, to show at least 100 kg during any 10 year period and that consumption commenced at least 5 years before clinical onset; note 40‑year cessation window (s 9(7); note to s 9(7)).

• TCDD and chemical agents: if asserting exposure to chemical agents contaminated by TCDD, document the activity (decanting, spraying, cleaning equipment, handling treated timber, dust shrouding, using contaminated cutting oils) and establish at least 1,000 cumulative hours within a consecutive 10 year period before clinical onset, with first exposure at least 5 years before clinical onset (s 9(8); Schedule 1 list of chemicals).

• Vietnam presence: if relying on s 9(9), obtain service records proving cumulative presence for at least 30 days in the areas and times described in Items 3A, 3B, 4 and 8 of Schedule 2 of the VEA; ensure the exposure was at least 5 years before clinical onset (s 9(9); Schedule 1).

• Polycyclic aromatic hydrocarbons and specified industries: show that the claimant worked in one of the “specified industry, manufacturing process or agent” categories (Schedule 1) and that exposure was for at least 1,500 cumulative hours with first exposure at least 5 years before clinical onset (s 9(18); Schedule 1).

• Welding: show continuous or cumulative use of manual welding equipment for welding metal for at least 10 years before clinical onset (s 9(19)).

• Other medical factors: obtain documented evidence for solid organ transplantation (excluding corneal transplant) (s 9(11)), HIV infection (s 9(12)), persistent laryngeal HPV 16/18 infection (s 9(13)), GERD duration (5 years) (s 9(16)), and opium inhalation (weekly on average for 10 years) (s 9(17)).

Step 5 , Document relationship to relevant service (s 10(1))

• Secure service records, deployment orders, unit diaries, ship logs and any contemporaneous documentation that links the exposure to the person’s relevant service category (Schedule 1 relevant service lists operational, peacekeeping, hazardous, British nuclear test defence service under the VEA, and warlike and non‑warlike service under the MRCA).

• If relying on environmental conditions or occupational tasks performed during service, obtain testimony, statements from fellow personnel, and unit records that corroborate the exposure and its timing.

Step 6 , Address the limitations of s 9(20) where applicable

• If invoking inability to obtain appropriate clinical management as a factor (s 9(20)), ensure the claimant’s malignant neoplasm of the larynx was suffered or contracted before or during, but did not arise out of, relevant service, as required by s 10(2). Support the claim with medical correspondence showing attempts to obtain management and records of denial, delay, or unavailability that materially contributed to disease progression.

Step 7 , Cross‑reference other SoPs where relevant (s 11)

• If a s 9 factor refers to a disease or injury covered by another SoP (for example, a factor that references another occupational disease instrument), obtain and apply that SoP’s factors as permitted by s 11. Provide references and comparative analysis showing how the other SoP’s factors are satisfied.

Step 8 , Prepare expert reports and statutory statements

• Where objective records are sparse, obtain expert medico‑legal reports that reconstruct clinical onset dates, exposure quantification (hours, pack‑years), and the nexus to service. Experts should reference the Schedule’s definitions and the SoP’s thresholds.

• Prepare sworn statements from the claimant, colleagues, commanders or medical staff that attest to the presence and duration of exposures, with particular attention to dates and environments.

Step 9 , Anticipate record gaps and prepare alternative evidentiary pathways

• Where contemporaneous documentation is unavailable, prepare corroborating affidavits, unit witness statements, and occupational history summaries. Experts should opine on the reliability of reconstructions and whether, on balance, the SoP’s threshold is met.

Step 10 , File and argue consistency with the SoP’s text

• Ensure submissions explicitly map documentary and expert evidence to the precise subparagraphs of s 9 and to the relationship requirement in s 10. If relying on an ICD‑10‑AM code, remind decision makers they must apply the textual definition in s 7(2) rather than ICD alone (s 7(3)-(4)).

Administrative practice tips

• Cross‑check Schedule 2 of the VEA when asserting Vietnam presence (as amended in 2024).

• Use the Schedule’s conversions for pack‑years and alcohol calculations to avoid arithmetic challenge (Schedule 1; note to s 9(7)).

• For exposures expressed in hours, present a clear aggregation methodology and supporting documentation explaining how cumulative hours were calculated.

• For infections and biological markers (HIV, HPV 16/18), obtain dated laboratory results, viral typing and pathology confirming persistent infection when required.

By following these steps and explicitly linking evidence to the SoP’s textual requirements (s 7; s 9; s 10; Schedule 1), claimants and advisers can align their factual case with the instrument’s criteria, minimise interpretive disputes and reduce the risk of administrative rejection on evidentiary grounds.